To develop an assay that could be used to evaluate clinical formalin-fixed paraffin-embedded (FFPE) tumor specimens, we evaluated EGFR:MET transcript ratios through BaseScope, an RNA-based in situ hybridization assay in which fluorescent signal area acts as a surrogate for RNA transcript expression. This evidence concerns the gene MET and neoplasm.